In this video, Hira Mian, MD, McMaster University, Hamilton, Canada, discusses the development of a prognostic survival model incorporating patient reported outcomes (PROs) which has been designed to assist in making treatment decisions for elderly patients with multiple myeloma. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.